InsiderTrades.com logo
WARNING: “Buffett Indicator” flashing for first time in 50 years
From Behind the Markets   |   Ad
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.
Take these 4 steps today to protect your retirement NOW

FRX Insider Trading

Insider Ownership Percentage: 16.20%
Insider Buying (Last 12 Months): C$112,360.75
Insider Selling (Last 12 Months): C$455,891.17

Fennec Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Fennec Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fennec Pharmaceuticals Share Price & Price History

Current Price: C$8.57
Price Change: ▲ Price Increase of +0.11 (1.30%)
As of 12/20/2024 06:17 PM ET

This chart shows the closing price history over time for FRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
We recommended Palantir in 2021, now we’re recommending this...
From Behind the Markets   |   Ad
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Click to get the name and ticker symbol

Fennec Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2024Rostislav Christov RaykovDirectorBuy796C$8.52C$6,779.05
11/18/2024Robert Christopher AndradeSenior OfficerBuy15,816C$3.43C$54,248.88
10/8/2024Chris Anigeron RallisDirectorSell1,406C$6.16C$8,662.08
10/2/2024Rostislav Christov RaykovDirectorSell2,431C$6.67C$16,212.34
9/4/2024Rostislav Christov RaykovDirectorSell2,431C$7.45C$18,115.81
7/5/2024Chris Anigeron RallisDirectorSell1,173C$6.03C$7,073.19
7/1/2024Rostislav Christov RaykovDirectorSell2,431C$6.13C$14,902.03
4/23/2024Adrian J. HaighSenior OfficerSell22,223C$9.32C$207,029.47
4/15/2024Adrian J. HaighSenior OfficerBuy22,222C$2.31C$51,332.82
4/15/2024Chris Anigeron RallisDirectorSell800C$10.45C$8,360.00
3/26/2024Chris Anigeron RallisDirectorSell2,114C$10.97C$23,190.58
3/26/2024Robert Christopher AndradeSenior OfficerSell13,975C$10.90C$152,345.67
11/24/2023Chris Anigeron RallisDirectorSell269C$8.25C$2,219.25
11/16/2023Khalid IslamDirectorBuy20,492C$2.44C$50,000.48
11/3/2023Rostislav Christov RaykovDirectorBuy74,793C$1.59C$118,920.87
4/28/2023Chris Anigeron RallisDirectorSell916C$8.34C$7,639.44
11/17/2022Chris Anigeron RallisDirectorSell333C$10.63C$3,538.6930,018
10/20/2022Chris Anigeron RallisDirectorSell2,068C$10.66C$22,035.3725,589
9/21/2022Robert Christopher AndradeSenior OfficerSell19,052C$11.02C$209,888.26176,721
9/12/2022Rostislav Christov RaykovDirectorSell16,666C$0.93C$15,479.3821,081,996
7/18/2022Chris Anigeron RallisDirectorBuy11,111C$0.59C$6,499.9432,036
See Full Table
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now

SEC Filings (Institutional Ownership Changes) for Fennec Pharmaceuticals (TSE:FRX)

52.78% of Fennec Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Fennec Pharmaceuticals logo
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Read More on Fennec Pharmaceuticals

Today's Range

Now: C$8.57
Low: C$8.47
High: C$8.57

50 Day Range

MA: C$7.12
Low: C$5.65
High: C$8.81

52 Week Range

Now: C$8.57
Low: C$5.65
High: C$15.43

Volume

5,800 shs

Average Volume

2,014 shs

Market Capitalization

C$234.48 million

P/E Ratio

85.70

Dividend Yield

2.02%

Beta

0.25

Who are the company insiders with the largest holdings of Fennec Pharmaceuticals?

Fennec Pharmaceuticals' top insider shareholders include:
  1. Adrian J Haigh (Senior Officer)
  2. Chris Anigeron Rallis (Director)
  3. Khalid Islam (Director)
  4. Robert Christopher Andrade (Senior Officer)
  5. Rostislav Christov Raykov (Director)
Learn More about top insider investors at Fennec Pharmaceuticals.
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin